Report Detail
Covid-19 Impact on Antiviral Oral Liquid Market, Global Research Reports 2020-2021
- RnM3961552 |
- 20 May, 2020 |
- Global |
- 129 Pages |
- QYResearch |
- Medical Industry
Antiviral Oral Liquid market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiviral Oral Liquid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antiviral Oral Liquid market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Antiviral Oral Liquid industry.
The key players covered in this study
Pfizer
Roche
Novartis
Merck
GlaxoSmithKline
Johnson & Johnson
AbbVie
Sanofi
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Novo Nordisk
Amgen
Gilead Sciences
CSL
Takeda Pharmaceuticals
Bayer
Celgene
Merck KGaA
Allergan
Market segment by Type, the product can be split into
Syrup
Oral suspension
Oral solution
Oral drop
Oral emulsion
Mixture
Market segment by Application, split into
Adults
Children
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Antiviral Oral Liquid status, future forecast, growth opportunity, key market and key players.
To present the Antiviral Oral Liquid development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Antiviral Oral Liquid are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Antiviral Oral Liquid Revenue
- 1.4 Covid-19 Implications on Market by Type
- 1.4.1 Global Antiviral Oral Liquid Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Syrup
- 1.4.3 Oral suspension
- 1.4.4 Oral solution
- 1.4.5 Oral drop
- 1.4.6 Oral emulsion
- 1.4.7 Mixture
- 1.5 Market by Application
- 1.5.1 Global Antiviral Oral Liquid Market Share by Application: 2020 VS 2026
- 1.5.2 Adults
- 1.5.3 Children
- 1.6 Coronavirus Disease 2019 (Covid-19): Antiviral Oral Liquid Industry Impact
- 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.6.2 Covid-19 Impact: Commodity Prices Indices
- 1.6.3 Covid-19 Impact: Global Major Government Policy
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends
- 2.1 Covid-19 Implications on Global Antiviral Oral Liquid Market Perspective (2015-2026)
- 2.2 Covid-19 Implications on Global Antiviral Oral Liquid Growth Trends by Regions
- 2.2.1 Antiviral Oral Liquid Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Antiviral Oral Liquid Historic Market Share by Regions (2015-2020)
- 2.2.3 Antiviral Oral Liquid Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Antiviral Oral Liquid Market Growth Strategy
- 2.3.6 Primary Interviews with Key Antiviral Oral Liquid Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
- 3.1 Global Top Antiviral Oral Liquid Players by Market Size
- 3.1.1 Global Top Antiviral Oral Liquid Players by Revenue (2015-2020)
- 3.1.2 Global Antiviral Oral Liquid Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Antiviral Oral Liquid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Antiviral Oral Liquid Market Concentration Ratio
- 3.2.1 Global Antiviral Oral Liquid Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Antiviral Oral Liquid Revenue in 2019
- 3.3 Antiviral Oral Liquid Key Players Head office and Area Served
- 3.4 Key Players Antiviral Oral Liquid Product Solution and Service
- 3.5 Date of Enter into Antiviral Oral Liquid Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
- 4.1 Global Antiviral Oral Liquid Historic Market Size by Type (2015-2020)
- 4.2 Global Antiviral Oral Liquid Forecasted Market Size by Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
- 5.1 Global Antiviral Oral Liquid Market Size by Application (2015-2020)
- 5.2 Global Antiviral Oral Liquid Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
- 6.1 North America Antiviral Oral Liquid Market Size (2015-2020)
- 6.2 Antiviral Oral Liquid Key Players in North America (2019-2020)
- 6.3 North America Antiviral Oral Liquid Market Size by Type (2015-2020)
- 6.4 North America Antiviral Oral Liquid Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
- 7.1 Europe Antiviral Oral Liquid Market Size (2015-2020)
- 7.2 Antiviral Oral Liquid Key Players in Europe (2019-2020)
- 7.3 Europe Antiviral Oral Liquid Market Size by Type (2015-2020)
- 7.4 Europe Antiviral Oral Liquid Market Size by Application (2015-2020)
8 China Impact of COVID-19
- 8.1 China Antiviral Oral Liquid Market Size (2015-2020)
- 8.2 Antiviral Oral Liquid Key Players in China (2019-2020)
- 8.3 China Antiviral Oral Liquid Market Size by Type (2015-2020)
- 8.4 China Antiviral Oral Liquid Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
- 9.1 Japan Antiviral Oral Liquid Market Size (2015-2020)
- 9.2 Antiviral Oral Liquid Key Players in Japan (2019-2020)
- 9.3 Japan Antiviral Oral Liquid Market Size by Type (2015-2020)
- 9.4 Japan Antiviral Oral Liquid Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
- 10.1 Southeast Asia Antiviral Oral Liquid Market Size (2015-2020)
- 10.2 Antiviral Oral Liquid Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Antiviral Oral Liquid Market Size by Type (2015-2020)
- 10.4 Southeast Asia Antiviral Oral Liquid Market Size by Application (2015-2020)
11 India Impact of COVID-19
- 11.1 India Antiviral Oral Liquid Market Size (2015-2020)
- 11.2 Antiviral Oral Liquid Key Players in India (2019-2020)
- 11.3 India Antiviral Oral Liquid Market Size by Type (2015-2020)
- 11.4 India Antiviral Oral Liquid Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
- 12.1 Central & South America Antiviral Oral Liquid Market Size (2015-2020)
- 12.2 Antiviral Oral Liquid Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Antiviral Oral Liquid Market Size by Type (2015-2020)
- 12.4 Central & South America Antiviral Oral Liquid Market Size by Application (2015-2020)
13Key Players Profiles
- 13.1 Pfizer
- 13.1.1 Pfizer Company Details
- 13.1.2 Pfizer Business Overview and Its Total Revenue
- 13.1.3 Pfizer Antiviral Oral Liquid Introduction
- 13.1.4 Pfizer Revenue in Antiviral Oral Liquid Business (2015-2020))
- 13.1.5 Pfizer Recent Development and Reaction to COVID-19
- 13.2 Roche
- 13.2.1 Roche Company Details
- 13.2.2 Roche Business Overview and Its Total Revenue
- 13.2.3 Roche Antiviral Oral Liquid Introduction
- 13.2.4 Roche Revenue in Antiviral Oral Liquid Business (2015-2020)
- 13.2.5 Roche Recent Development and Reaction to COVID-19
- 13.3 Novartis
- 13.3.1 Novartis Company Details
- 13.3.2 Novartis Business Overview and Its Total Revenue
- 13.3.3 Novartis Antiviral Oral Liquid Introduction
- 13.3.4 Novartis Revenue in Antiviral Oral Liquid Business (2015-2020)
- 13.3.5 Novartis Recent Development and Reaction to COVID-19
- 13.4 Merck
- 13.4.1 Merck Company Details
- 13.4.2 Merck Business Overview and Its Total Revenue
- 13.4.3 Merck Antiviral Oral Liquid Introduction
- 13.4.4 Merck Revenue in Antiviral Oral Liquid Business (2015-2020)
- 13.4.5 Merck Recent Development and Reaction to COVID-19
- 13.5 GlaxoSmithKline
- 13.5.1 GlaxoSmithKline Company Details
- 13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
- 13.5.3 GlaxoSmithKline Antiviral Oral Liquid Introduction
- 13.5.4 GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2015-2020)
- 13.5.5 GlaxoSmithKline Recent Development and Reaction to COVID-19
- 13.6 Johnson & Johnson
- 13.6.1 Johnson & Johnson Company Details
- 13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
- 13.6.3 Johnson & Johnson Antiviral Oral Liquid Introduction
- 13.6.4 Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2015-2020)
- 13.6.5 Johnson & Johnson Recent Development and Reaction to COVID-19
- 13.7 AbbVie
- 13.7.1 AbbVie Company Details
- 13.7.2 AbbVie Business Overview and Its Total Revenue
- 13.7.3 AbbVie Antiviral Oral Liquid Introduction
- 13.7.4 AbbVie Revenue in Antiviral Oral Liquid Business (2015-2020)
- 13.7.5 AbbVie Recent Development and Reaction to COVID-19
- 13.8 Sanofi
- 13.8.1 Sanofi Company Details
- 13.8.2 Sanofi Business Overview and Its Total Revenue
- 13.8.3 Sanofi Antiviral Oral Liquid Introduction
- 13.8.4 Sanofi Revenue in Antiviral Oral Liquid Business (2015-2020)
- 13.8.5 Sanofi Recent Development and Reaction to COVID-19
- 13.9 Bristol-Myers Squibb
- 13.9.1 Bristol-Myers Squibb Company Details
- 13.9.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
- 13.9.3 Bristol-Myers Squibb Antiviral Oral Liquid Introduction
- 13.9.4 Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2015-2020)
- 13.9.5 Bristol-Myers Squibb Recent Development and Reaction to COVID-19
- 13.10 AstraZeneca
- 13.10.1 AstraZeneca Company Details
- 13.10.2 AstraZeneca Business Overview and Its Total Revenue
- 13.10.3 AstraZeneca Antiviral Oral Liquid Introduction
- 13.10.4 AstraZeneca Revenue in Antiviral Oral Liquid Business (2015-2020)
- 13.10.5 AstraZeneca Recent Development and Reaction to COVID-19
- 13.11 Eli Lilly
- 10.11.1 Eli Lilly Company Details
- 10.11.2 Eli Lilly Business Overview and Its Total Revenue
- 10.11.3 Eli Lilly Antiviral Oral Liquid Introduction
- 10.11.4 Eli Lilly Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.11.5 Eli Lilly Recent Development and Reaction to COVID-19
- 13.12 Novo Nordisk
- 10.12.1 Novo Nordisk Company Details
- 10.12.2 Novo Nordisk Business Overview and Its Total Revenue
- 10.12.3 Novo Nordisk Antiviral Oral Liquid Introduction
- 10.12.4 Novo Nordisk Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.12.5 Novo Nordisk Recent Development and Reaction to COVID-19
- 13.13 Amgen
- 10.13.1 Amgen Company Details
- 10.13.2 Amgen Business Overview and Its Total Revenue
- 10.13.3 Amgen Antiviral Oral Liquid Introduction
- 10.13.4 Amgen Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.13.5 Amgen Recent Development and Reaction to COVID-19
- 13.14 Gilead Sciences
- 10.14.1 Gilead Sciences Company Details
- 10.14.2 Gilead Sciences Business Overview and Its Total Revenue
- 10.14.3 Gilead Sciences Antiviral Oral Liquid Introduction
- 10.14.4 Gilead Sciences Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.14.5 Gilead Sciences Recent Development and Reaction to COVID-19
- 13.15 CSL
- 10.15.1 CSL Company Details
- 10.15.2 CSL Business Overview and Its Total Revenue
- 10.15.3 CSL Antiviral Oral Liquid Introduction
- 10.15.4 CSL Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.15.5 CSL Recent Development and Reaction to COVID-19
- 13.16 Takeda Pharmaceuticals
- 10.16.1 Takeda Pharmaceuticals Company Details
- 10.16.2 Takeda Pharmaceuticals Business Overview and Its Total Revenue
- 10.16.3 Takeda Pharmaceuticals Antiviral Oral Liquid Introduction
- 10.16.4 Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.16.5 Takeda Pharmaceuticals Recent Development and Reaction to COVID-19
- 13.17 Bayer
- 10.17.1 Bayer Company Details
- 10.17.2 Bayer Business Overview and Its Total Revenue
- 10.17.3 Bayer Antiviral Oral Liquid Introduction
- 10.17.4 Bayer Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.17.5 Bayer Recent Development and Reaction to COVID-19
- 13.18 Celgene
- 10.18.1 Celgene Company Details
- 10.18.2 Celgene Business Overview and Its Total Revenue
- 10.18.3 Celgene Antiviral Oral Liquid Introduction
- 10.18.4 Celgene Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.18.5 Celgene Recent Development and Reaction to COVID-19
- 13.19 Merck KGaA
- 10.19.1 Merck KGaA Company Details
- 10.19.2 Merck KGaA Business Overview and Its Total Revenue
- 10.19.3 Merck KGaA Antiviral Oral Liquid Introduction
- 10.19.4 Merck KGaA Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.19.5 Merck KGaA Recent Development and Reaction to COVID-19
- 13.20 Allergan
- 10.20.1 Allergan Company Details
- 10.20.2 Allergan Business Overview and Its Total Revenue
- 10.20.3 Allergan Antiviral Oral Liquid Introduction
- 10.20.4 Allergan Revenue in Antiviral Oral Liquid Business (2015-2020)
- 10.20.5 Allergan Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Antiviral Oral Liquid. Industry analysis & Market Report on Antiviral Oral Liquid is a syndicated market report, published as Covid-19 Impact on Antiviral Oral Liquid Market, Global Research Reports 2020-2021. It is complete Research Study and Industry Analysis of Antiviral Oral Liquid market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
